Spruce Biosciences reports Q1 EPS (28c), consensus (29c)
PremiumThe FlySpruce Biosciences reports Q1 EPS (28c), consensus (29c)
4M ago
Spruce Biosciences announces upcoming poster presentation
Premium
The Fly
Spruce Biosciences announces upcoming poster presentation
5M ago
Spruce Biosciences’ Compliance Hurdle: Navigating Sarbanes-Oxley to Protect Market Value
Premium
Company Announcements
Spruce Biosciences’ Compliance Hurdle: Navigating Sarbanes-Oxley to Protect Market Value
6M ago
Spruce Biosciences price target lowered to $3 from $8 at JMP Securities
PremiumThe FlySpruce Biosciences price target lowered to $3 from $8 at JMP Securities
6M ago
Spruce Biosciences downgraded to Sector Perform from Outperform at RBC Capital
Premium
The Fly
Spruce Biosciences downgraded to Sector Perform from Outperform at RBC Capital
6M ago
Spruce Biosciences down 74% at $1.35 after resumption of trade
Premium
The Fly
Spruce Biosciences down 74% at $1.35 after resumption of trade
6M ago
Spruce Biosciences cuts workforce 21%, terminates CAHmelia-203 study
PremiumThe FlySpruce Biosciences cuts workforce 21%, terminates CAHmelia-203 study
6M ago
Spruce Biosciences says CAHmelia-203 study did not meet efficacy endpoint
Premium
The Fly
Spruce Biosciences says CAHmelia-203 study did not meet efficacy endpoint
6M ago
Spruce Biosciences says Phase CAH study missed efficacy endpoint
Premium
The Fly
Spruce Biosciences says Phase CAH study missed efficacy endpoint
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100